Matthew Casbon
Sales & Marketing at VERONA PHARMA PLC
Profile
Matthew Casbon is currently the Vice President-Sales, Marketing & Training at Verona Pharma Plc since 2022.
Previously, he worked as the Senior Director-Marketing at Salix Pharmaceuticals Ltd.
from 2010 to 2015.
He also served as the Executive Director-Marketing at Chimerix, Inc. and as the Vice President-Marketing at Zevra Therapeutics, Inc. in 2016.
Additionally, he was the Senior Vice President-Global Strategic Marketing at Niox Group Plc.
Mr. Casbon completed his undergraduate degree at West Chester University of Pennsylvania.
Matthew Casbon active positions
| Companies | Position | Start |
|---|---|---|
| VERONA PHARMA PLC | Sales & Marketing | 2022-08-23 |
Former positions of Matthew Casbon
| Companies | Position | End |
|---|---|---|
| NIOX GROUP PLC | Corporate Officer/Principal | 2018-09-30 |
| ZEVRA THERAPEUTICS, INC. | Sales & Marketing | 2016-08-31 |
| SALIX PHARMACEUTICALS, LTD. | Sales & Marketing | 2014-12-31 |
| CHIMERIX, INC. | Sales & Marketing | - |
Training of Matthew Casbon
| West Chester University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| NIOX GROUP PLC | Health Services |
| Private companies | 1 |
|---|---|
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Matthew Casbon
